［1］Craciun S, Marks JA, Balskus EP. Characterization of choline trimethylamine-lyase expands the chemistry of glycyl radical enzymes［J］. Acs Chemical Biology, 2014, 9: 1408-1413.
［2］Zhu Y, Jameson E, Crosatti M, et al. Carnitine metabolism to trimethylamine by an unusual rieske-type oxygenase from human microbiota［J］. Proc Natl Acad Sci U S A, 2014, 111: 4268-4273.
［3］Schugar RC, Willard B, Wang Z, et al. Postprandial gut microbiota-driven choline metabolism links dietary cues to adipose tissuedysfunction［J］. Adipocyte, 2018, 7(1): 49-56.
［4］Tomlinson JAP, Wheeler DC.The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronickidney disease［J］. Kidney Int, 2017, 92(4): 809-815.
［5］李树彬, Adh Ikaricm, 高修仁. 炎症、炎症介质和代谢综合征［J］. 新医学, 2006,37(2): 131-134.
［6］Shan Z, Sun T, Huang H, et al. Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2diabetes［J］. Am J Clin Nutr, 2017, 106(3): 888-894.
［7］Tang WH, Wang Z, Li XS, et al. Increased trimethylamine N-oxide portends high mortality risk independent of glycemic control in patients with type 2 diabetes mellitus［J］. Clin Chem, 2017, 63(1): 297-306.
［8］Schugar RC, Shih DM, Warrier M, et al. The tmao-producing enzyme flavin-containing monooxygenase 3 regulates obesity and the beiging of white adipose tissue［J］. Cell Rep, 2017, 19(12): 2451-2461.
［9］Lontchi-Yimagou E, Sobngwi E, Matsha TE, et al. Diabetes mellitus and inflammation［J］. Curr Diab Rep, 2013, 13(3): 435-444.
［10］Al-Obaide MAI, Singh R, Datta P, et al. Gut microbiota-dependent trimethylamine-N-oxide and serum biomarkers in patients with T2DM and advanced ckd［J］. J Clin Med, 2017, 6(9).
［11］Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease［J］. Nature, 2011, 472(7341): 57-63.
［12］Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis［J］. Nat Med, 2013, 19(5): 576-585.
［13］Geng J, Yang C, Wang B, et al. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway［J］. Biomed Pharmacother, 2018, 97: 941-947.
［14］Ma G, Pan B, Chen Y, et al. Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion［J］. Biosci Rep, 2017, 37(2):BSR20160244.
［15］Seldin MM, Meng Y, Qi H, et al. Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-kappab［J］. J Am Heart Assoc,2016,5(2):pii:e002767.
［16］Organ CL, Otsuka H, Bhushan S, et al. Choline diet and its gut microbe-derived metabolite, trimethylamine N-oxide, exacerbate pressure overload-induced heart failure［J］. Circ Heart Fail, 2016, 9: e002314.
［17］Troseid M, Ueland T, Hov JR, et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure［J］. J Intern Med, 2015, 277(6): 717-726.
［18］Tang WH, Wang Z, Fan Y, et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis［J］. J Am Coll Cardiol, 2014, 64(18): 1908-1914.
［19］周素平, 杨成明. 炎症和心力衰竭［J］. 心血管病学进展, 2007,28(3): 493-496.
［20］罗健, 张源明. 高血压: 一种慢性低级别炎症性疾病［J］. 心血管病学进展, 2010, 31(4): 567-569.
［21］Ufnal M, Jazwiec R, Dadlez M, et al. Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats［J］. Can J Cardiol, 2014, 30(12): 1700-1705.
［22］Ke Y, Li D, Zhao M, et al. Gut flora-dependent metabolite trimethylamine-N-oxide accelerates endothelial cell senescenceand vascular aging through oxidative stress［J］. Free Radic Biol Med, 2018, 116: 88-100.
［23］Li D, Ke Y, Zhan R, et al. Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice［J］. Aging Cell, 2018: e12768.
［24］Li T, Chen Y, Gua C, et al. Elevated circulating trimethylamine N-oxide levels contribute to endothelial dysfunction in aged rats through vascular inflammation and oxidative stress［J］. Front Physiol, 2017, 8: 350.
［25］Xu R, Wang Q. Towards Understanding brain-gut-microbiome connections in alzheimer's disease［J］. Bmc Systems Biology, 2016, 10 Suppl 3: 63.
［26］张紫萱, 田绍文, 游咏. 神经炎症在神经退行性疾病和精神疾病中的病理生理作用［J］. 中南医学科学杂志, 2017, 45(3): 312-314.
［27］Del Rio D, Zimetti F, Caffarra P, et al. The gut microbial metabolite trimethylamine-N-oxide is present in human cerebrospinal fluid［J］. Nutrients, 2017, 9(10): 1053.
［28］康安, 郑啸, 文红梅, 等. 炎症信号在脑-肠轴中的传递及药物干预机制研究进展［J］. 中国临床药理学与治疗学, 2012, 17(12): 1407-1412.
［29］蒋建烨, 田湉, 张艳. Nlrp3炎症体与炎症性疾病［J］. 微生物学免疫学进展, 2012, 40(1): 79-82.
［30］Sun X, Jiao X, Ma Y, et al. Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ros-txnip-nlrp3 inflammasome［J］. Biochem Biophys Res Commun, 2016, 481: 63-70.
［31］Chen ML, Zhu XH, Ran L, et al. Trimethylamine-N-oxide induces vascular inflammation by activating the Nlrp3 inflammasome through the Sirt3-Sod2-mtros signaling pathway［J］. J Am Heart Assoc, 2017, 6(9). pii: e006347.
［32］Boini KM, Hussain T, Li PL, et al. Trimethylamine-N-oxide instigates Nlrp3 inflammasome activation and endothelial dysfunction［J］. Cell Physiol Biochem, 2017, 44(1): 152-162.
［33］Yue C, Yang X, Li J, et al. Trimethylamine N-oxide prime NLRP3 inflammasome via inhibiting ATG16L1-induced autophagyin colonic epithelial cells［J］. Biochem Biophys Res Commun, 2017, 490(2): 541-551.
［34］Hayden MS, Ghosh S. Nf-Kappab In Immunobiology［J］. Cell Res, 2011, 21(2): 223-244.
［35］Yu L, Meng G, Huang B, et al. A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation［J］. Int J Cardiol, 2018, 255: 92-98.
［36］Sarao LK, Arora M. Probiotics, prebiotics, and microencapsulation: A review［J］. Crit Rev Food Sci Nutr, 2017, 57(2): 344-371.
［37］Zmora N, Zilberman-Schapira G, Suez J, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features［J］. Cell, 2018, 174(6): 1388-1405.
［38］Qiu L, Yang D, Tao X, et al. Enterobacter aerogenes ZDY01 attenuates choline-induced trimethylamine N-oxide levels by remodeling gut microbiota in mice［J］. J Microbiol Biotechnol, 2017, 27(8): 1491-1499.
［39］Qiu L, Tao X, Xiong H, et al. Lactobacillus plantarum Zdy04 exhibits a strain-specific property of lowering tmao via the modulation of gut microbiota in mice［J］. Food Funct, 2018, 9: 4299-4309.
［40］Ramezani A, Nolin TD, Barrows IR, et al. Gut colonization with methanogenic archaea lowers plasma trimethylamine N-oxide concentrations in apolipoprotein e-/- mice［J］. Sci Rep, 2018, 8: 14752.
［41］Malik M, Suboc T M, Tyagi S, et al. Lactobacillus plantarum 299v supplementation improves vascular endothelial function and reduces inflammatory biomarkers in men with stable coronary artery disease［J］. Circ Res, 2018, 123(9): 1091-1102.
［42］Tripolt NJ, Leber B, Triebl A, et al. Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study［J］. Atherosclerosis, 2015, 242(1): 141-144.
［43］Boutagy NE, Neilson AP, Osterberg KL, et al. Probiotic supplementation and trimethylamine-N-oxide production following a high-fat diet［J］. Obesity (Silver Spring), 2015, 23(12): 2357-2363.
［44］Borges NA, Stenvinkel P, Bergman P, et al. Effects of probiotic supplementation on trimethylamine-N-oxide plasma levels in hemodialysis patients: a pilot study［J］. Probiotics Antimicrob Proteins, 2018.
［45］Craciun S, Balskus EP. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme［J］. Proc Natl Acad Sci U S A, 2012, 109(52): 21307-21312.
［46］Martinez-Del Campo A, Bodea S, Hamer HA, et al. Characterization and detection of a widely distributed gene cluster that predicts anaerobic choline utilization by human gut bacteria［J］. Mbio, 2015, 6.
［47］Romano KA, Martinez-Del Campo A, Kasahara K, et al. Metabolic, epigenetic, and transgenerational effects of gut bacterial choline consumption［J］. Cell Host Microbe, 2017, 22(3): 279-290 e277.
［48］Wang Z, Roberts AB, Buffa JA, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis［J］. Cell, 2015, 163(7): 1585-1595.
［49］Roberts AB, Gu X, Buffa JA, et al. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential［J］. Nat Med, 2018, 24(9): 1407-1417.
［50］Skye SM, Zhu W, Romano KA, et al. Microbial transplantation with human gut commensals containing cutc is sufficient to transmit enhanced platelet reactivity and thrombosis potential［J］. Circ Res, 2018, 123(10): 1164-1176.